TrialBreast cancer research and treatment2018

Highly favorable physiological responses to concurrent resistance and high-intensity interval training during chemotherapy: the OptiTrain breast cancer trial.

Sara Mijwel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.